Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4003343 | American Journal of Ophthalmology | 2011 | 9 Pages |
Abstract
Anti-VEGF agents are effective in preventing vision loss and improving vision in multiple diseases, including diabetic retinopathy, neovascular age-related macular degeneration, and retinal vein occlusions. Despite a substantial decrease in its use for these conditions in recent years, laser therapies continue to serve important roles in our ability to combat retinal pathologic features and will remain a pivotal component of our practices for at least the next several years.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ankur M. Shah, Neil M. Bressler, Lee M. Jampol,